A61M2210/06

TOPICAL MEDICATION FOR SCALP
20180296815 · 2018-10-18 ·

A composition for treating a hair-growing surface from which hair follicles extend, the composition comprising an opaque material having sufficient shape and stability for covering the hair-growing surface, the opaque material including a medicament for promoting hair growth.

BRAINWAVE REGULATION DEVICE AND BRAINWAVE REGULATION METHOD
20180289919 · 2018-10-11 ·

A brainwave regulation device adapted to transmit signals to or receive signals from a control device. The brainwave regulation device includes a head-wearable element, a control module, at least one brainwave sensor and at least one ear bone oscillator. The control module is disposed on the head-wearable element and adapted to transmits signals to or receive signals from the control device. The at least one brainwave sensor is connected to the head-wearable element and adapted to transmit signals to or receive signals from the control module and transmit the sensed brainwave signal to the control device through the control module. The at least one ear bone oscillator is connected to the head-wearable element, and adapted to transmit signals to or receive signals from the control module and receive control signals from the control device through the control module to generate oscillation. The present invention also provides a brainwave regulation method adapted for use with a brainwave regulation device and for brainwave regulation.

VIRTUAL REALITY METHODS AND APPARATUS WHICH USE OR INCLUDE BRAIN ACTIVITY SENSORS
20180280656 · 2018-10-04 ·

Integrated systems for providing audio, video, light stimulus and/or measuring brain activity through the use of one or more electrodes, e.g., EEG dermatrodes, are described. A system, e.g., a head mounted VR device, for providing stimulation to a user and detecting user responses to said stimulation includes a head mount, a plurality of light emitting elements, e.g., sets of LEDs, a housing secured to said head mount, and at least one or more electrodes for making contact with skin of a user. In various embodiments, the system further determines a user's mental state and provides audio and/or visual feedback to the user.

RESPIRATORY PRESSURE THERAPY SYSTEM
20240307639 · 2024-09-19 ·

The present technology is directed to a respiratory pressure therapy system, that includes a plenum chamber pressurisable to a therapeutic pressure above ambient air pressure, a seal-forming structure to form a seal with an entrance to the patient's airways to maintain said therapeutic pressure in the plenum chamber throughout the patient's respiratory cycle in use, a positioning and stabilising structure constructed and arranged to provide an elastic force to hold the seal-forming structure in a therapeutically effective position on the patient's head, a blower configured to generate the flow of air and pressurise the plenum chamber to the therapeutic pressure, the blower having a motor, the blower being connected to the plenum chamber such that the blower is suspended from the patient's head and the axis of rotation of the motor is perpendicular to the patient's sagittal plane, and a power supply configured to provide electrical power to the blower.

METHODS AND SYSTEMS FOR DRAINING CEREBROSPINAL FLUID INTO THE VENOUS SYSTEM

Methods for treating hydrocephalus using a shunt, the shunt having one or more CSF intake openings in a distal portion, a valve disposed in a proximal portion of the shunt, and a lumen extending between the one or more CSF intake openings and the valve, the method comprises deploying the shunt in a body of a patient so that the distal portion of the shunt is at least partially disposed within a CP angle cistern, a body of the shunt is at least partially disposed within an IPS of the patient, and the proximal portion of the shunt is at least partially disposed within or proximate to a JV of the patient, wherein, after deployment of the shunt, CSF flows from the CP angle cistern to the JV via the shunt lumen at a flow rate in a range of 5 ml per hour to 15 ml per hour.

METHODS AND SYSTEMS FOR TREATING HYDROCEPHALUS

Methods for treating hydrocephalus using a shunt, the shunt having one or more CSF intake openings in a distal portion, a valve disposed in a proximal portion of the shunt, and a lumen extending between the one or more CSF intake openings and the valve, the method comprises deploying the shunt in a body of a patient so that the distal portion of the shunt is at least partially disposed within a CP angle cistern, a body of the shunt is at least partially disposed within an IPS of the patient, and the proximal portion of the shunt is at least partially disposed within or proximate to a JV of the patient, wherein, after deployment of the shunt, CSF flows from the CP angle cistern to the JV via the shunt lumen at a flow rate in a range of 5 ml per hour to 15 ml per hour.

METHODS AND SYSTEMS FOR MODULATING STIMULI TO THE BRAIN WITH BIOSENSORS
20180250494 · 2018-09-06 · ·

Visual and auditory stimuli are provided to a patient to treat various neurological disorders or conditions and/or to provide improved mental or physical performance. The visual and auditory stimuli are provided by a wearable headset or sleep mask that may be comfortably worn by a user, such as in bed to induce sleep. The wearable headset or sleep mask includes, or works in cooperation with, sensors that determine the state of the user and modify the operation of the headset for treating various disorders or contentions.

Methods and systems for treating hydrocephalus

Methods for treating hydrocephalus using a shunt, the shunt having one or more CSF intake openings in a distal portion, a valve disposed in a proximal portion of the shunt, and a lumen extending between the one or more CSF intake openings and the valve, the method comprises deploying the shunt in a body of a patient so that the distal portion of the shunt is at least partially disposed within a CP angle cistern, a body of the shunt is at least partially disposed within an IPS of the patient, and the proximal portion of the shunt is at least partially disposed within or proximate to a JV of the patient, wherein, after deployment of the shunt, CSF flows from the CP angle cistern to the JV via the shunt lumen at a flow rate in a range of 5 ml per hour to 15 ml per hour.

Systems for enhancing sleep

Methods, devices and systems for improving sleep (including reducing sleep onset and maintenance of sleep duration), enhancing, or increasing sleep, including (but not limited to) treating sleeping disorders such as insomnia.

LUCID DREAM STIMULATOR, SYSTEMS, AND RELATED METHODS

A method for communicating with devices may include monitoring brain activity of a subject via an EEG monitoring system coupled to the subject. The method also may include detecting a predefined state of brain activity of the subject. Further, based on the detecting the predefined state, the method may include wirelessly transmitting instructions from the EEG monitoring system to the at least one household device to adjust a setting of the at least one household device.